Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Cleveland Biolabs, Inc. (NQ: CBLI)
1.630 USD  +0.070 (+4.49%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Cleveland Biolabs, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Cleveland BioLabs (Nasdaq:CBLI) Trading Down 35% After Negative Update
April 04, 2012
Shawshank, VA 4/4/12 ( StreetBeat ) -- Cleveland BioLabs, Inc. ( Nasdaq:CBLI ) today announced that the Company received a response from the Biomedical Advanced Research and Development Authority of... Read More
from Street Beat: Articles
Cleveland BioLabs (Nasdaq:CBLI) Trading Down 35% After Negative Update
April 04, 2012
Shawshank, VA 4/4/12 ( StreetBeat ) -- Cleveland BioLabs, Inc. ( Nasdaq:CBLI ) today announced that the Company received a response from the Biomedical Advanced Research and Development Authority of... Read More
from Street Beat: Articles
Cleveland BioLabs (Nasdaq:CBLI) Trading Down 35% After Negative Update
April 04, 2012
Shawshank, VA 4/4/12 ( StreetBeat ) -- Cleveland BioLabs, Inc. ( Nasdaq:CBLI ) today announced that the Company received a response from the Biomedical Advanced Research and Development Authority of... Read More
from Street Beat: Articles
Morning Movers 04/04: (MAGS) (GMXR) Higher; (CBLI) (PATK) (SNDK) (WBMD) Lower
April 04, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7323619 for the full story. Read More
from StreetInsider.com News Articles
Watch for Continued Losses in Shares of Cleveland Biolabs (CBLI)
April 04, 2012
from Comtex SmarTrend® News Briefs
Pre-Open Movers 4/4: (GMXR) (DDIC) (SBUX) Higher; (CBLI) (TSLA) (SNDK) Lower (more...)
April 04, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7323387 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs Provides Update on BARDA Development Funding Process and Meetings With FDA
April 03, 2012
Conference Call Scheduled for April 4 Read More
from GlobeNewswire News Releases
Cleveland BioLabs (CBLI) Shares Volatile Following New Outperform Rating at Rodman & Renshaw
March 14, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7269399 for the full story. Read More
from StreetInsider.com News Articles
Cleveland Biolabs, Inc. (CBLI) Misses Q4 EPS by 2c
March 13, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7266529 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs Announces Start of Advanced Cancer Trial for CBLB502
March 12, 2012
from GlobeNewswire News Releases
Cleveland BioLabs to Host Quarterly Update Call on March 14
March 01, 2012
from GlobeNewswire News Releases
Unusual 11 Midday Movers 02/27: (ALIM) (BPAX) (ATPG) (CAAS) Higher; (DNDN) (IMI) (BCPC) Lower
February 27, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7216531 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs Announces Science Publication on Molecular Mechanisms Underlying CBLB502's Interaction With TLR5
February 16, 2012
from GlobeNewswire News Releases
Cleveland BioLabs to Present at 14th Annual BIO CEO and Investor Conference
February 06, 2012
from Marketwired News Releases
Cleveland BioLabs revamps top execs
January 24, 2012
A management alteration at Cleveland BioLabs Inc. includes a change of CEOs. The Buffalo-based drug maker (NASDAQ: CBLI) said Tuesday that Michael Fonstein, Ph.D., has stepped down chief executive... Read More
from National Business News - Local Business News | bizjournals
Cleveland Biolabs (CBLI) Fonstein to Step Down as CEO, Will Remain Pres; Kogan Named Interim CEO
January 24, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7102997 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs Announces Management Reorganization
January 24, 2012
Optimizes Executive Resources to Advance CBLB502 and Promote Business Development Read More
from Marketwired News Releases
Cleveland BioLabs Publishes Manuscript on New Radiation Countermeasure CBLB613
January 17, 2012
from Marketwired News Releases
Cleveland BioLabs to Present at Noble Financial Eighth Annual Equity Conference
January 11, 2012
from Marketwired News Releases
Cleveland BioLabs to Present at 4th Annual LD MICRO Growth Conference
December 01, 2011
from Marketwired News Releases
Cleveland BioLabs to Host Quarterly Update Call on November 10
November 01, 2011
from Marketwired News Releases
International Journal of Radiation Oncology, Biology and Physics Publishes Cleveland BioLabs Study of CBLB502 Protection From Radiation Dermatitis and Oral Mucositis in Head and Neck Cancer Model
October 24, 2011
from Marketwired News Releases
Cleveland BioLabs Announces Opening of New IND for CBLB502 in Cancer Patients
October 19, 2011
Roswell Park Cancer Institute Approves First Trial Protocol Read More
from Marketwired News Releases
CEO Video Interviews With Exclusive Growth Companies Now Available on Equities.com
October 07, 2011
from GlobeNewswire News Releases
Journal of Immunology Publishes Study of Cleveland BioLabs' Drug CBLB502 in Acute Renal Ischemic Failure
October 03, 2011
from Marketwired News Releases
Cleveland BioLabs (CBLI) Enters Joint Stock Agreement with RUSNANO for Panacela Labs Funding
September 26, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6809838 for the full story. Read More
from StreetInsider.com News Articles
Cleveland BioLabs and RUSNANO Enter Into Agreement to Form New Joint Venture to Develop Innovative Compounds for Cancer and Infectious Disease
September 26, 2011
from Marketwired News Releases
Cleveland BioLabs awarded $5M grant
September 23, 2011
A Buffalo biotech firm has received a $5 million grant from the Russian government to support cancer research. Incuron LLC, a joint venture between Cleveland BioLabs Inc. (NASDAQ: CBLI) and a... Read More
from National Business News - Local Business News | bizjournals
Cleveland BioLabs Subsidiary Incuron Receives $5 Million Grant From Russian Federation Government Initiative
September 19, 2011
from Marketwired News Releases
Unusual 11 Mid-Day Movers 09/09: (ULTA) (CGA) (CONN) Higher; (AATI) (VRSN) (MTRX) Lower
September 09, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6774965 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here